Acute Bacterial Rhinosinusitis (ABRS)
This is acute bacterial rhinosinusitis requiring antibiotic therapy with amoxicillin 500 mg three times daily for 7-10 days, based on the 2-week duration of purulent symptoms meeting diagnostic criteria for bacterial superinfection. 1, 2
Diagnostic Reasoning
Your symptom constellation—sinus pressure, purulent nasal drainage, bilateral ear congestion, headache, cough, and chills persisting for 2 weeks—meets established criteria for ABRS rather than simple viral rhinosinusitis. 1
Key diagnostic criteria met:
- Duration >10 days without improvement is the primary indicator distinguishing bacterial from viral infection, as viral URIs typically resolve within 7-10 days and fewer than 2% progress to bacterial superinfection 1
- Purulent nasal drainage combined with facial pressure/pain are the two symptoms with highest correlation to bacterial disease 1, 2
- Bilateral ear congestion reflects mucosal continuity of the upper respiratory tract, where sinus inflammation extends to the middle ear 2
- Chills and headache suggest systemic inflammatory response to bacterial infection 1
The 2-week timeframe is critical: sinus aspiration studies demonstrate significant bacterial growth in approximately 60% of patients with URI symptoms lasting ≥10 days, compared to predominantly viral pathogens in shorter durations. 1
First-Line Antibiotic Treatment
Amoxicillin 500 mg orally three times daily for 7-10 days is the evidence-based first-line therapy. 2, 3
This targets the three most common bacterial pathogens:
When to use amoxicillin-clavulanate instead:
- Recent antibiotic use within 4-6 weeks 3, 4
- Recent hospitalization 3
- Immunocompromised state 3
- Geographic areas with high beta-lactamase-producing bacterial resistance (>30%) 4, 5
If you have any of these risk factors, start with amoxicillin-clavulanate (high-dose: 2000 mg/125 mg twice daily or 875 mg/125 mg twice daily) instead. 4
Symptomatic Adjunctive Therapy
Combine antibiotics with the following for symptom relief:
- Intranasal saline irrigation 2-3 times daily—no rebound effect and mechanically clears purulent secretions 6, 3
- Intranasal corticosteroid spray (e.g., fluticasone, mometasone) twice daily to reduce mucosal inflammation and promote sinus drainage 2, 3, 7
- Oral decongestant (pseudoephedrine 120 mg twice daily) for nasal congestion 6
- Analgesics (ibuprofen 400-600 mg every 6-8 hours or acetaminophen) for headache and facial pain 1, 6
Avoid topical decongestants (oxymetazoline) beyond 3-5 days due to rebound congestion risk. 6
Follow-Up and Red Flags
Reassess in 3-5 days to confirm clinical improvement (reduced purulent discharge, decreased facial pressure, improved energy). 2
Switch to amoxicillin-clavulanate if no improvement after 3-5 days of amoxicillin monotherapy, as this suggests beta-lactamase-producing organisms. 2, 3
Return immediately for:
- Periorbital edema, erythema, or vision changes—suggests orbital complications requiring urgent evaluation 6, 3
- Severe unilateral facial pain with high fever (>39°C)—may indicate complicated sinusitis 6, 3
- Severe headache with neck stiffness or mental status changes—raises concern for intracranial extension 6
- Worsening after initial improvement—"double sickening" pattern suggesting resistant organism or complication 3
Common Pitfalls to Avoid
Do not withhold antibiotics in favor of "watchful waiting" when symptoms have persisted 2 weeks—this duration definitively exceeds the viral URI timeline and meets bacterial infection criteria. 1, 3
Do not obtain imaging (CT or X-ray) for straightforward ABRS meeting clinical criteria, as radiographic findings have only 61% specificity and do not distinguish viral from bacterial causes. 1, 3
Do not assume this is allergic rhinitis—the evolution from initial URI to persistent purulent discharge, absence of itching/sneezing, and lack of seasonal pattern argue against allergy. 2, 6
Do not use newer-generation antihistamines (loratadine, cetirizine) for symptom relief, as they lack anticholinergic activity and are ineffective for post-viral upper airway symptoms; use first-generation antihistamines (e.g., dexbrompheniramine) if antihistamine therapy is desired. 6